CER

F. Hoffmann-La Roche Ltd Group sales were +6% at constant exchange rates (CER)1, -5% when reported in CHF and…

Swiss pharma giant Roche Holding AG’s RHHBY first-quarter 2026 results were affected by currency headwinds. Sales totaled $18.8…

Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 14.9 billion for the third quarter of…

Swiss pharma giant Roche Holding AG (RHHBY) reported sales of CHF 30.9 billion for the first half of…

Swiss pharma giant Roche Holding AG’s RHHBY 2025 results were affected by currency headwinds. Sales totaled $74.4 billion,…

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc